We have observed
17 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PEPTIDES FOR SUPPRESSING INFLAMMATION REACTIONS IN HEMODIALYSIS
MELANOCYTE-STIMULATION HORMONE FOR SUPPRESSING INFLAMMATION REACTIONS IN HEMODIALYSIS
MULTI-CHAMBER CONTAINER FOR PRODUCING MEDICAL SOLUTIONS
PHARMACEUTICAL COMPOSITIONS CONTAINING CARBOXYLATED STARCH
CONNECTOR WITH DOUBLE LUMEN TUBE
Low pollutant dialysis solution
BAG WITH FLOW EQUALISATION
BAG WITH SHRINK-WRAPPED, FLEXURALLY RIGID PLASTIC PART
Adsorber granulate for removing of uremic toxins
APPARATUS FOR RECEIVING A SYRINGE INTO A FLUID-DISPENSING APPARATUS, METHOD THEREFOR, AND USE OF SUCH A RECEPTACLE
METHOD FOR THE ULTRASONIC DEGASSING OF LIQUIDS FOR DIALYSIS
SENSOR SYSTEM FOR DETECTING PHASES AND/OR PHASE TRANSITIONS IN PERITONEAL DIALYSIS
DEVICE FOR SEPARATING BLOOD INTO THE COMPONENTS THEREOF AND METHOD THEREFOR AND USE OF SAID TYPE OF DEVICE
ADSORBER GRANULES FOR REMOVING URAEMIC TOXINS
MULTICHAMBER BAG OPENING AID
METHOD AND DEVICE FOR DETERMINING CENTRAL SYSTOLIC BLOOD PRESSURE
DEVICE FOR CONNECTING A PUNCTURABLE VIAL TO A CONTAINER OR TO A FLUID LINE AND TRANSFER OF THE CONTENTS OF A PUNCTURABLE VIAL INTO A CONTAINER OR INTO A FLUID LINE, AND METHOD THEREFOR AND USE OF SUCH DEVICE